Nirsevimab for Prevention of RSV Hospitalizations in Infants. Reply
- PMID: 38507766
- DOI: 10.1056/NEJMc2400983
Nirsevimab for Prevention of RSV Hospitalizations in Infants. Reply
Comment on
-
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.N Engl J Med. 2023 Dec 28;389(26):2425-2435. doi: 10.1056/NEJMoa2309189. N Engl J Med. 2023. PMID: 38157500 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources